Loading...
XCNQORI
Market cap8mUSD
Aug 21, Last price  
0.40CAD
Name

Orion Nutraceuticals Inc

Chart & Performance

D1W1MN
XCNQ:ORI chart
P/E
—
P/S
—
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
75.85%
Rev. gr., 5y
%
Revenues
0k
Net income
-62k
L-77.90%
-13,108,054-229,389-1,233,376-4,957,597-279,691-61,822
CFO
-57k
L+9.97%
-1,782,562-47,979-935,038-82,923-51,771-56,935
Earnings
Feb 07, 2025

Profile

Orion Nutraceuticals Inc. focuses on the drug for treating asthma and chronic obstructive pulmonary diseases in Canada. The company was formerly known as Cline Capital Corp. Orion Nutraceuticals Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada.
URL
https://www.orionnutra.ca/
IPO date
Oct 17, 2018
Employees
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑052023‑052022‑052021‑052020‑052019‑052018‑05
Income
Revenues
Cost of revenue
172
282
Unusual Expense (Income)
NOPBT
(172)
(282)
NOPBT Margin
Operating Taxes
2,338
Tax Rate
NOPAT
(172)
(2,620)
Net income
(62)
-77.90%
(280)
-94.36%
(4,958)
301.95%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
82
90
44
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
(111)
86
35
Cash flow
Cash from operating activities
(57)
(52)
(83)
CAPEX
Cash from investing activities
254
(188)
Cash from financing activities
(8)
46
FCF
70
60
(285)
Balance
Cash
193
4
9
Long term investments
Excess cash
193
4
9
Stockholders' equity
(2,314)
(915)
(636)
Invested Capital
1,419
90
44
ROIC
ROCE
20.87%
47.69%
EV
Common stock shares outstanding
29,308
29,308
29,308
Price
Market cap
EV
EBITDA
(172)
(282)
EV/EBITDA
Interest
2,338
Interest/NOPBT